Get earlier, mechanistic insight into DILI risk with HUB Organoids’ human liver organoid platform:

• Donor-diverse liver organoid biobank
• Multiparametric live-cell assay: mitochondrial dysfunction, oxidative stress, lipid dysregulation,viability
• Supports lead optimisation and safer candidate selection in preclinical development

 Sponsored by